These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33357045)

  • 1. Evaluation of decontamination efficacy of four antineoplastics (ifosfamide, 5-fluorouracil, irinotecan, and methotrexate) after deliberate contamination.
    Palamini M; Floutier M; Gagné S; Caron N; Bussières JF
    J Occup Environ Hyg; 2021 Feb; 18(2):43-50. PubMed ID: 33357045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of decontamination efficacy of cleaning solutions on stainless steel and glass surfaces contaminated by 10 antineoplastic agents.
    Queruau Lamerie T; Nussbaumer S; Décaudin B; Fleury-Souverain S; Goossens JF; Bonnabry P; Odou P
    Ann Occup Hyg; 2013 May; 57(4):456-69. PubMed ID: 23223271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of decontamination strategies for cyclophosphamide.
    Soubieux A; Palamini M; Tanguay C; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):413-422. PubMed ID: 31370747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?
    Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of healthcare workers' exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study.
    Palamini M; Dufour A; Therrien R; Delisle JF; Mercier G; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2020 Dec; 26(8):1864-1870. PubMed ID: 32138611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
    Roland C; Caron N; Bussières JF
    J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficiency of antineoplastic drug contamination removal by widely used disinfectants-laboratory and hospital studies.
    Bláhová L; Kuta J; Doležalová L; Kozáková Š; Krovová T; Bláha L
    Int Arch Occup Environ Health; 2021 Oct; 94(7):1687-1702. PubMed ID: 33738516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleaning Efficiencies of Three Cleaning Agents on Four Different Surfaces after Contamination by Gemcitabine and 5-fluorouracile.
    Böhlandt A; Groeneveld S; Fischer E; Schierl R
    J Occup Environ Hyg; 2015; 12(6):384-92. PubMed ID: 25751496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External contamination of antineoplastic drug containers from a Canadian wholesaler.
    Hilliquin D; Bussières JF
    J Oncol Pharm Pract; 2020 Mar; 26(2):423-427. PubMed ID: 31446868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of environmental contamination with antineoplastic drugs in 33 Canadian hospitals.
    Merger D; Tanguay C; Langlois E; Lefebvre M; Bussières JF
    Int Arch Occup Environ Health; 2014 Apr; 87(3):307-13. PubMed ID: 23471647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device.
    Guillemette A; Langlois H; Voisine M; Merger D; Therrien R; Mercier G; Lebel D; Bussières JF
    J Oncol Pharm Pract; 2014 Dec; 20(6):426-32. PubMed ID: 24395542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Decontamination Efficacy of Cleaning Solutions on a Biological Safety Cabinet Workbench Contaminated by Cyclophosphamide.
    Adé A; Chauchat L; Frève JO; Gagné S; Caron N; Bussières JF
    Can J Hosp Pharm; 2017; 70(6):407-414. PubMed ID: 29298999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental contamination with methotrexate in Canadian community pharmacies.
    Merger D; Tanguay C; Langlois É; Lefebvre M; Bussières JF
    J Am Pharm Assoc (2003); 2013; 53(4):423-6. PubMed ID: 23892817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the Use of Ozone Water as a Chemical Decontamination Agent for Antineoplastic Drugs in Clinical Settings.
    Kato G; Mitome H; Teshima K; Tawa K; Hakuba Y; Tanabe T; Funahashi T; Hatae N; Koike Y; Hasebe M; Hidaka N; Tanaka M; Akira K
    Ann Work Expo Health; 2023 Feb; 67(2):241-251. PubMed ID: 36416483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 48 Canadian hospitals.
    Poupeau C; Tanguay C; Caron NJ; Bussières JF
    J Oncol Pharm Pract; 2018 Jan; 24(1):9-17. PubMed ID: 27799608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy.
    Anastasi M; Rudaz S; Queruau Lamerie T; Odou P; Bonnabry P; Fleury-Souverain S
    Ann Occup Hyg; 2015 Aug; 59(7):895-908. PubMed ID: 25979920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Sectional Evaluation of Surface Contamination with Antineoplastic Drugs in Canadian Health Care Centres.
    Hilliquin D; Tanguay C; Gagné S; Caron NJ; Bussières JF
    Can J Hosp Pharm; 2019; 72(5):377-384. PubMed ID: 31692608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy of a self-cleaning automated compounding system for the decontamination of cytotoxic drugs.
    Telleria N; García N; Grisaleña J; Algaba N; Bergareche E; Tamés MJ; Cajaraville G
    J Oncol Pharm Pract; 2021 Sep; 27(6):1343-1353. PubMed ID: 32854575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers.
    Delafoy C; Roussy C; Hudon AF; Cirtiu CM; Caron N; Bussières JF; Tanguay C
    J Oncol Pharm Pract; 2023 Mar; 29(2):338-347. PubMed ID: 35018847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.